Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement.
about
A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastasesDose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver.Transarterial chemoembolization (TACE) for colorectal liver metastases--current status and critical review.Evaluation of extrahepatic collateral arteries in hepatocellular carcinoma in three independent groups in a single center.Complete response in a patient with liver metastases from breast cancer employing hepatic arterial infusion 5-fluorouracil based chemotherapy plus systemic nab-paclitaxel.
P2860
Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Phase I clinical trial of hepa ...... nd dominant liver involvement.
@ast
Phase I clinical trial of hepa ...... nd dominant liver involvement.
@en
type
label
Phase I clinical trial of hepa ...... nd dominant liver involvement.
@ast
Phase I clinical trial of hepa ...... nd dominant liver involvement.
@en
prefLabel
Phase I clinical trial of hepa ...... nd dominant liver involvement.
@ast
Phase I clinical trial of hepa ...... nd dominant liver involvement.
@en
P2093
P2860
P50
P1476
Phase I clinical trial of hepa ...... nd dominant liver involvement.
@en
P2093
Cynthia Uehara
David Hong
Jennifer Wheler
Katherine Letourneau
Stephen E McRae
P2860
P2888
P304
P356
10.1007/S00280-010-1482-Y
P577
2010-10-13T00:00:00Z
P5875
P6179
1035122147